Pathophysiologic interactions in skeletal metastasis

Cancer

Volumn 88, Issue 12 SUPPL., 2000, Pages 2912-2918

  Orr, F William ^a   Lee, Joanne ^a   Duivenvoorden, Wilhelmina C M ^b   Singh, Gurmit ^b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Adhesion; Bone; Bone resorption; Cell migration; Chemotaxis; Growth factors; Metalloproteinase; Metastasis

Indexed keywords

CELL ADHESION MOLECULE; GROWTH FACTOR; INTEGRIN; MATRIX METALLOPROTEINASE;

BONE METASTASIS; CELL ADHESION; CELL GROWTH; CELL MIGRATION; CHEMOTAXIS; CONFERENCE PAPER; OSTEOLYSIS; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; TUMOR CELL;

EID: 0034659807     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20000615)88:12+<2912::aid-cncr6>3.0.co;2-8     Document Type: Conference Paper

References (76)

1. Rubens RD. Bone metastases - the clinical problem. Eur J Cancer 1998;34:210-3.
2. Pantel K, Cote RJ, Fodstad O. Detection and clinical importance of micrometastatic disease. J Natl Cancer lnst 1999; 91:1113-24.
3. Paget S. The distribution of secondary growths in cancer of the breast. Lancet 1889;1:571-3.
4. Koyama T, Hasebe T, Tsuda H, Hirohashi S, Sasaki S, Fukutomi T, et al. Histological factors associated with initial bone metastasis of invasive ductal carcinoma of the breast. Jpn J Cancer Res 1999;90:294-300.
5. Engebraaten O, Fodstad O. Site-specific experimental metastasis patterns of two human breast cancer cell lines in nude rats. Int J Cancer 1999;82:219-25.
6. Bouizar Z, Spyratos F, De vernejoul MC. The parathyroid hormone-related protein (PTHrP) gene: use of downstream TATA promoter and PTHrP 1-139 coding pathways in primary breast cancers vary with the occurrence of bone metastasis. J Bone Miner Res 1999;14:406-14.
7. Kim RH, Sodek J. Transcription of the bone sialoprotein gene is stimulated by v-Src acting through an inverted CCAAT box. Cancer Res 1999;59:565-71.
8. Hampl M, Hampl JA, Reiss G, Schackert G, Saeger HD, Schackert HK. Loss of heterozygosity accumulation in primary breast carcinomas and additionally in corresponding distant metastases is associated with poor outcome. Clin Cancer Res 1999;5:1417-25.
9. Hildebrandt T, Freiherr I, Klostermann S, Kaul S, Zendman AJ, Van Muijen GN, et al. Identification of URIM, a novel gene up-regulated in metastasis. Anticancer Res 1999;19: 525-30.
10. Batson OV. The role of vertebral veins in metastatic processes. Ann Intern Med 1942;16:38-46.
11. Harada M, Shimizu A, Nakamura Y, Nemoto R. Role of the vertebral venous system in metastatic spread of cancer cells to the bone. Adv Exp Med Biol 1992;324:83-92.
12. De Bruyn PPH. Structural substrates of bone marrow function. Semin Hematology 1981;18:179-93.
13. + immune T cells. Cancer Res 1998;58:5439-46.
14. Hahn T, Or R, Segall H, Karov Y. Human bone marrow-derived mitogenic stimulation selective for breast carcinoma and neuroblastoma cells. Int J Cancer 1998;78:624-8.
15. Rabbani SA, Gladu J, Harakidas P, Jamison B, Goltzman D. Over-production of parathyroid hormone-related peptide results in increased osteolytic skeletal metastasis by prostate cancer cells in vivo. Int J Cancer 1999;80:257-64.
16. Zhang Y, Fujita N, Oh-hara T, Morinaga Y, Nakagawa T, Yamada M, et al. Production of interleukin-11 in bone-derived endothelial cells and its role in the formation of osteolytic bone metastasis. Oncogene 1998;16:693-703.
17. Garrett IR. Bone destruction in cancer. Semin Oncol 1993; 20:4-9.
18. Quinn JMW, Athanasou NA. Tumour infiltrating macrophages are capable of bone resorption. J Cell Sci 1992;101: 681-6.
19. Eilon G, Mundy GR. Direct resorption of bone by human breast cancer cells in vitro. Nature 1978;276:726-8.
20. Sanchez-Sweatman OH, Lee J, Orr FW, Singh G. Direct osteolysis induced by metastatic murine melanoma cells: role of matrix metalloproteinases. Eur J Cancer 1997;33:918-25.
21. Lee J, Bone EA, Watson PH, Orr FW. Effect of matrix metalloproteinase (MMP) inhibitor Batimastat on bone metastasis [abstract]. Proc Am Assoc Cancer Res 1998;39:299.
22. Votta BJ, Levy MA, Badger A, Bradbeer J, Dodds RA, James IE, et al. Peptide aldehyde inhibitors of cathepsin K inhibit bone resorption both in vitro and in vivo. J Bone Miner Res 1997;12:1396-406.
23. Rice DP, Kim HJ, Thesleff I. Detection of gelatinase B expression reveals osteoclastic bone resorption as a feature of early calvarial bone development. Bone 1997;21:479-86.
24. Woessner JF Jr. The family of matrix metalloproteinases. Ann NY Acad Sci 1994;732:11-21.
25. Kusano K, Miyaura C, Inada M, Tamura T, Ito A, Nagase H, et al. Regulation of matrix metalloproteinases (MMP-2, -3, -9, and -13) by interleukin-1 and interleukin-6 in mouse calvaria: association of MMP induction with bone resorption. Endocrinology 1998;139:1338-45.
26. Meikle MC, Bord S, Hembry RM, Reynolds JJ. The synthesis of collagenase, gelatinase-A (72 kDa) and -B (95 kDa), and TIMP-1 and -2 by human osteoblasts from normal and arthritic bone. Bone 1995;17:255-60.
27. Bord S, Horner A, Hembry RM, Reynolds JJ, Compston JE. Production of collagenase by human osteoblasts and osteoclasts in vivo. Bone 1996;19:35-40.
28. Okada Y, Naka K, Kawamura K, Matsumoto T, Nakanishi I, Fujimoto N, et al. Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/type IV collagenase = gelatinase B) in osteoclasts: implications for bone resorption. Lab Invest 1995;72:311-22.
29. Stearns ME, Wang M. Alendronate blocks metalloproteinase secretion and bone collagen I release by PC-3 ML cells in SCID mice. Clin Exp Metast 1998;16:693-702.
30. Barille S, Akhoundi C, Collette M, Mellerin MP, Rapp MJ, Harousseau JL, et al. Metalloproteinases in multiple myeloma: production of matrix metalloproteinase-9 (MMP-9), activation of proMMP-2, and induction of MMP-1 by myeloma cells. Blood 1997;90:1649-55.
31. Ueda Y, Imai K, Tsuchiya H, Fujimoto N, Nakanishi I, Katsuda S, et al. Matrix metalloproteinase 9 (gelatinase B) is expressed in multinucleated giant cells of human giant cell tumor of bone and is associated with vascular invasion. Am J Pathol 1996;148:611-22.
32. Stearns ME, Wang M. Effects of alendronate and taxol on pc 3 ml cell bone metastases in scid mice. Invasion Metastasis 1996;16:116-31.
33. Yoneda T, Sasaki A, Dunstan C, Williams PJ, Bauss F, De Clerck YA, et al. Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase 2. J Clin Invest 1997;99:2509-17.
34. Ishiduka Y, Mochizuki R, Yanai K, Takatsuka M, Nonomura T, Niida S, et al. Induction of hydroxyapatite resorptive activity in bone marrow cell populations resistant to bafilomycin Al by a factor with restricted expression to bone and brain, neurochondrin. Biochim Biophys Acta 1999;1450: 92-8.
35. Clarke NW, McClure J, George NJ. Osteoblast function and osteomalacia in metastatic prostate cancer. Eur Urol 1993; 24:286-90.
36. Koutsilieris M. Osteoblastic metastasis in advanced prostate cancer [review]. Anticancer Res 1993;13:443-9.
37. Rabbani SA, Mazar AP, Bernier SM, Haq M, Bolivar I, Henkin J, et al. Structural requirements for the growth factor activity of the amino-terminal domain of urokinase. J Biol Chem 1992;267:1-4.
38. Koutsilieris M, Frenette G, Lazure C, Lehoux JG, Govindan MV, Polychronakos C. Urokinase-type plasminogen activator: a paracrine factor regulating the bioavailability of IGFs in PA-III cell-induced osteoblastic metastases. Anticancer Res 1993;13:481-6.
39. Autzen P, Robson CN, Bjartell A, Malcolm AJ, Johnson MI, Neal DE, et al. Bone morphogenetic protein 6 in skeletal metastases from prostate cancer and other common human malignancies. Br J Cancer 1998;78:1219-23.
40. Martinez J, Fuentes M, Cambiazo V, Santibanez JF. Bone extracellular matrix stimulates invasiveness of estrogen-responsive human mammary MCF-7 cells. Int J Cancer 1999; 83:278-82.
41. Manishen WJ, Sivananthan K, Orr FW. Resorbing bone stimulates tumor cell growth. A role for the host microenvironment in bone metastasis. Am J Pathol 1986;123:39-45.
42. Schwarz LC, Gingras M-C, Goldberg G, Greenberg AH, Wright JA. Loss of growth factor dependence and conversion of transforming growth factors-1 inhibition to stimulation in metastatic H-ras-transformed murine fibroblasts. Cancer Res 1988;48:6999-7003.
43. Kerbel R. Expression of multi-cytokine resistance and multi-growth factor independence in advanced stage metastatic cancer. Am J Pathol 1992;141:519-24.
44. Choki I, Sourla A, Reyes-Moreno C, Koutsilieris M. Osteoblast-derived growth factors enhance adriamycin-cytostasis of MCF-7 human breast cancer cells. Anticancer Res 1998; 18:4213-24.
45. Arguello F, Furlanetto RW, Baggs RB, Graves BT, Harwell, SE, Cohen HJ, et al. Incidence and distribution of experimental metastases in mutant mice with defective organ microenvironments (genotypes S1/S1d and W/Wv). Cancer Res 1992;52:2304-9.
46. Kostenuik PJ, Singh G, Suyama KL, Orr FW. A quantitative model for spontaneous bone metastasis: evidence for a mitogenic effect of bone on Walker 256 cancer cells. Clin Exp Metastasis 1992;10:403-10.
47. Kostenuik PJ, Singh G, Suyama KL, Orr FW. Stimulation of bone resorption results in a selective increase in the growth rate of spontaneously metastatic Walker 256 cancer cells in bone. Clin Exp Metast 1992;10:411-8.
48. Okado T, Hawley RG. Adhesion molecules involved in the binding of murine myeloma cells to bone marrow stromal elements. Int J Cancer 1995;63:823-30.
49. Nakai M, Mundy GR, Williams PJ, Boyce B, Yoneda T. A synthetic antagonist to laminin inhibits the formation of osteolytic metastases by human melanoma cells in nude mice. Cancer Res 1992;52:5395-9.
50. Matsuura N, Puzon-McLaughlin W, Irie A, Morikawa Y, Kakudo K, Takada Y. Induction of experimental bone metastasis in mice by transfection of integrin alpha 4 beta 1 into tumor cells. Am J Pathol 1996;148:55-61.
51. Kostenuik PJ, Sanchez Sweatman O, Orr FW, Singh G. Bone cell matrix promotes the adhesion of human prostatic carcinoma cells via the alpha 2 beta 1 integrin. Clin Exp Metastasis 1996; 14:19-26.
52. Zheng DQ, Woodard AS, Fornaro M, Tallini G, Languino LR. Prostatic carcinoma cell migration via alpha(v)beta3 integrin is modulated by a focal adhesion kinase pathway. Cancer Res 1999;59:1655-64.
53. Sung V, Stubbs JT, Fisher L, Aaron AD, Thompson EW. Bone sialoprotein supports breast cancer cell adhesion proliferation and migration through differential usage of the alpha(v)-beta3 and alpha(v)beta5 integrins. J Cell Physiol 1998; 176: 482-94.
54. Uchiyama H, Barut BA, Mohrbacher AF, Chauhan D, Anderson KC. Adhesion of human myeloma-derived cell lines to bone marrow stromal cells stimulates interleukin-6 secretion. Blood 1993;82:3712-20.
55. Kostenuik PJ, Singh G, Orr FW. Transforming growth factor beta upregulates the integral-mediated adhesion of human prostatic carcinoma cells to type I collagen. Clin Exp Metastasis 1997;15:41-52.
56. Orr FW. Cancer cell chemotaxis. Adv Mol Cell Biol 1994;9: 153-89.
57. Lemieux P, Harvey J, Guise T, Dallas M, Oesterreich S, Yin J, et al. Low cell motility induced by hsp27 overexpression decreases osteolytic bone metastases of human breast cancer cells in vivo. J Bone Miner Res 1999;14:1570-5.
58. Orr W, Varani J, Gondek MD, Ward PA, Mundy GR. Chemotactic responses of tumor cells to products of resorbing bone. Science 1979;203:176-9.
59. Orr FW, Varani J, Gondek MD, Ward PA, Mundy GR, Partial characterization of a bone-derived chemotactic factor for tumor cells. Am J Pathol 1980;99:43-52.
60. Wass JA, Varani J, Piontek GE, Ward PA, Orr FW. Responses of normal and malignant cells to collagen, collagen-derived peptides and the C5-related tumor cell chemotactic peptide. Cell Differ 1981;10:329-32.
61. Mundy GR, DeMartino S, Rowe DW. Collagen and collagen-derived fragments are chemotactic for tumor cells. J Clin Invest 1981;68:1102-5.
62. Mundy GR, Poser JW. Chemotactic activity of the gamma-carboxyglutamic acid containing protein in bone. Calcif Tissue Int 1983;35:164-8.
63. Orr FW, Millar-Book W, Singh G. Chemotactic activity of bone and platelet-derived TGF-beta for bone-metastasizing rat walker 256 carcinosarcoma cells. Invasion Metastasis 1990;10:241-52.
64. Festuccia C, Bologna M, Gravina GL, Guerra F, Angelucci A, Villanova I, et al. Osteoblast conditioned media contain TGF-betal and modulate the migration of prostate tumor cells and their interactions with extracellular matrix components. Int J Cancer 1999;81:395-403.
65. Festuccia C, Giunciuglio D, Guerra F, Villanove I, Angelucci A, Manduca P, et al. Osteoblasts modulate secretion of urokinase-type plasminogen activator (uPA) and matrix metalloproteinase-9 (MMP-9) in human prostate cancer cells promoting migration and matrigel invasion. Oncol Res 1999;11:17-31.
66. Yin JJ, Selander K, Chirgwin JM, Dallas M, Grubbs BG, Wieser R, et al. TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. J Clin Invest 1999;103:197-206.
67. Matrisian LM. Matrix metalloproteinase gene expression. Ann NY Acad Sci 1994;732:42-50.
68. Benbow U, Brinckerhoff CE. The AP-1 site and MMP regulation: what is all the fuss about? Matrix Biol 1997;15:519-26.
69. Duivenvoorden WC, Hirte HW, Singh G. Transforming growth factor betal acts as an inducer of matrix metalloproteinase expression and activity in human bone-metastasizing cancer cells. Clin Exp Metastasis 1999;17:27-34.
70. Orr FW, Sanchez Sweatman OH, Kostenuik P, Singh G. Tumor-bone interactions in skeletal metastasis. Clin Orthop 1995;19-33.
71. Guise T, Mundy GR. Cancer and bone. Endocr Rev 1998;19: 18-54.
72. Haq M, Goltzman D, Tremblay G, Brodt P. Rat prostate adenocarcinoma cells disseminate to bone and adhere preferentially to bone marrow-derived endothelial cells. Cancer Res 1992;52:4613-9.
73. Lehr JE, Pienta KJ. Preferential adhesion of prostate cancer cells to a human bone marrow endothelial cell line [see comments]. J Natl Cancer Inst 1998;90:118-23.
74. Ridley RC, Xaio H, Hata H, Woodliff J, Epstein J, Sanderson RD. Expression of syndecan regulates human myeloma plasma cell adhesion to type I collagen. Blood 1993;81:767-74.
75. Lang SH, Clarke NW, George NJR, Testa NG. Primary prostatic epithelial cell binding to human bone marrow stroma and the role of alpha 2 beta 1 integrin. Clin Exp Metastasis 1997;15:218-27.
76. Hullinger TG, McCauley LK, Dejoode ML, Somerman MJ. Effect of bone proteins on human prostate cancer cell lines in vitro. Prostate 1998;36:14-22.